Pituitary adenoma: A radiotherapeutic perspective

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 4, 2010, Pages 408-419

  Platta, Christopher S ^a,b   MacKay, Christopher ^c   Welsh, James S ^a,b,d,e  

^a Department of Human Oncology ^*  (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c Wausau Neurosurgery SC   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UW Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; PERGOLIDE; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ANATOMY; CANCER RADIOTHERAPY; CANCER STAGING; CUSHING DISEASE; EMBRYOLOGY; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; MEDICAL LITERATURE; NELSON SYNDROME; PHYSIOLOGY; PROLACTINOMA; REVIEW; TUMOR CLASSIFICATION; ADENOMA; ADULT; FOLLOW UP; HISTOLOGY; HYPOPHYSIS; HYPOPHYSIS TUMOR; HYPOTHALAMUS; INCIDENCE; MORTALITY; ORGAN SIZE; PATHOLOGY; RETROSPECTIVE STUDY; UNITED STATES;

ADENOMA; ADULT; FOLLOW-UP STUDIES; HUMANS; HYPOTHALAMUS; INCIDENCE; ORGAN SIZE; PITUITARY GLAND; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 77956639837     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31819d878d     Document Type: Review

References (156)

1. Ghostine S, Ghostine MS, Johnson WD. Radiation therapy in the treatment of pituitary tumors. Neurosurg Focus. 2008;24:E8.
2. Burrow GN, Wortzman G, Rewcastle NB, et al. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med. 1981;304:156-158.
3. Kovacs K, Horvath E. Pathology of pituitary tumors. Endocrinol Metab Clin North Am. 1987;16:529-551.
4. Herman V, Fagin J, Gonsky R, et al. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 1990;71:1427-1433.
5. Freda PU, Wardlaw SL. Clinical review 110: Diagnosis and treatment of pituitary tumors. J Clin Endocrinol Metab. 1999;84:3859-3866.
6. Gramegna A. Gramegna A. Un cas d'acromegalie traite par la radiotherapie [article in Spanish]. Rev Neurol. 1909;17:15-17.
7. Mondok A, Szeifert GT, Mayer A, et al. Treatment of pituitary tumors: Radiation. Endocrine. 2005;28:77-85.
8. Kernohan J, Sayre G. Tumors of the Pituitary Gland and Infundibulum. Washington, DC: Armed Forces Institute of Pathology; 1956.
9. Tavaris J, Pile-Spellman J. Neuroradiology. Baltimore, MD: Williams & Wilkins; 1996.
10. Welsh J, Wharam MD. Pituitary Adenoma: A review with an emphasis on radiotherapeutic management. Neurosurg Q 1999;9:163-196.
11. Nussey SS, Whitehead SA. Endocrinology: An Integrated Approach. Oxford: Taylor and Francis; 2001.
12. Max MB, Deck MD, Rottenberg DA. Pituitary metastasis: Incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology. 1981;31:998-1002.
13. Aaberg TM Jr, Kay M, Sternau L. Metastatic tumors to the pituitary. Am J Ophthalmol. 1995;119:779-785.
14. Alexander AA, Niktash N, Kardon DE, et al. Ectopic nasopharyngeal pituitary adenoma resected with endoscopic technique. Ear Nose Throat J. 2008;87:E8-E10.
15. Martin J, ed. Neuroanatomy: Text and Atlas. New York, NY: Elsevier; 1989.
16. Thorner M, Vance M, Haovarth E, et al. The anterior pituitary. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. 8th ed. Philadelphia, PA: WB Saunders; 1992.
17. Grigsby P. Pituitary. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. Philadelphia, PA: Lippincott-Raven; 1997.
18. Leavens ME, McCutcheon IF, Samaan NA. Management of pituitary adenomas. Oncology (Williston Park). 1992;6:69 -79; discussion 79-80.
19. Scheithauer BW, Horvath E, Kovacs K, et al. Plurihormonal pituitary adenomas. Semin Diagn Pathol. 1986;3:69-82.
20. Hardy J, Vezina JL. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol. 1976;15:261-273.
21. Schlechte JA, Sherman BM, Chapler FK, et al. Long-term follow-up of women with surgically treated prolactin-secreting tumors. J Clin Endocrinol Metab. 1986;62:1296-1301.
22. Colao A, Sarno AD, Cappabianca P, et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol. 2003;148:325-331. (Pubitemid 36410718)
23. Delgrange E, Trouillas J, Maiter D, et al. Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J Clin Endocrinol Metab. 1997;82:2102-2107.
24. Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006;65:265-273.
25. Naidich MJ, Russell EJ. Current approaches to imaging of the sellar region and pituitary. Endocrinol Metab Clin North Am. 1999;28:45-79, vi.
26. Colao A, di Sarno A, Pivonello R, et al. Dopamine receptor agonists for treating prolactinomas. Expert Opin Investig Drugs. 2002;11:787-800.
27. Gillam MP, Molitch ME, Lombardi G, et al. Advances in the treatment of prolactinomas. Endocr Rev. 2006;27:485-534.
28. Thorner MO, Perryman RL, Rogol AD, et al. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab. 1981;53:480-483.
29. Zarate A, Canales ES, Cano C, et al. Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine. Acta Endocrinol (Copenh). 1983;104:139-142.
30. Passos VQ, Souza JJ, Musolino NR, et al. Long-term follow-up of prolactinomas: Normoprolactinemia after bromocriptine withdrawal. J Clin Endocrinol Metab. 2002;87:3578-3582.
31. Charpentier G, de Plunkett T, Jedynak P, et al. Surgical treatment of prolactinomas. Short- and long-term results, prognostic factors. Horm Res. 1985;22:222-227.
32. Fahlbusch R, Buchfelder M. Present status of neurosurgery in the treatment of prolactinomas. Neurosurg Rev. 1985;8:195-205.
33. Randall RV, Laws ER Jr, Abboud CF, et al. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas: Results in 100 patients. Mayo Clin Proc. 1983;58:108-121.
34. Rodman EF, Molitch ME, Post KD, et al. Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma. JAMA. 1984;252: 921-924.
35. Halberg FE, Sheline GE. Radiotherapy of pituitary tumors. Endocrinol Metab Clin North Am. 1987;16:667-684.
36. Feigenbaum SL, Downey DE, Wilson CB, et al. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: Long term follow-up. J Clin Endocrinol Metab. 1996;81:1711-1719.
37. Wiebe RH, Kramer RS, Hammond CB. Surgical treatment of prolactinsecreting microadenomas. Am J Obstet Gynecol. 1979;134:49-55.
38. van't Verlaat JW. The use of surgery for the treatment of prolactinomas. Acta Endocrinol (Copenh). 1993;129(suppl 1):34-37.
39. Gokalp HZ, Deda H, Attar A, et al. The neurosurgical management of prolactinomas. J Neurosurg Sci. 2000;44:128-132.
40. Scanlon MF, Peters JR, Thomas JP, et al. Management of selected patients with hyperprolactinaemia by partial hypophysectomy. Br Med J (Clin Res Ed). 1985;291:1547-1550.
41. Sheline G, Grossman A, Jones AE, et al. Radiation Therapy for Prolactinomas. New York, NY: Raven Press; 1984.
42. Grigsby PW, Stokes S, Marks JE, et al. Prognostic factors and results of radiotherapy alone in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys. 1988;15:1103-1110.
43. Rush SC, Newall J. Pituitary adenoma: The efficacy of radiotherapy as the sole treatment. Int J Radiat Oncol Biol Phys. 1989;17:165-169.
44. Antunes JL, Housepian EM, Frantz AG. Prolactin-secreting pituitary tumors. Ann Neurol. 1977;2:148-153.
45. Gomez F, Reyes FI, Faiman C. Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases. Am J Med. 1977;62:648-660.
46. Kleinberg DL, Noel GL, Frantz AG. Galactorrhea: A study of 235 cases, including 48 with pituitary tumors. N Engl J Med. 1977;296:589-600.
47. Mehta AE, Reyes FI, Faiman C. Primary radiotherapy of prolactinomas: Eight- to 15-year follow-up. Am J Med. 1987;83:49-58.
48. Hughes MN, Llamas KJ, Yelland ME, et al. Pituitary adenomas: Long-term results for radiotherapy alone and post-operative radiotherapy. Int J Radiat Oncol Biol Phys. 1993;27:1035-1043.
49. Littley MD, Shalet SM, Beardwell CG, et al. Hypopituitarism following external radiotherapy for tumors in adults. Q J Med. 1989;70:145-160.
50. Tsagarakis S, Grossman A, Plowman PN, et al. Megavoltage pituitary irradiation in the management of prolactinomas: Long-term follow-up. Clin Endocrinol (Oxf). 1991;34:399-406.
51. Grossman A, Cohen BL, Charlesworth M, et al. Treatment of prolactinomas with megavoltage radiotherapy. Br Med J (Clin Res Ed). 1984;288:1105-1109.
52. Grigsby PW, Simpson JR, Emami BN, et al. Prognostic factors and results of surgery and postoperative irradiation in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys. 1989;16:1411-1417.
53. Sasaki R, Murakami M, Okamoto Y, et al. The efficacy of conventional radiation therapy in the management of pituitary adenoma. Int J Radiat Oncol Biol Phys. 2000;47:1337-1345.
54. Carter JN, Tyson JE, Tolis G, et al. Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med. 1978;299:847-852.
55. Witt TC. Stereotactic radiosurgery for pituitary tumors. Neurosurg Focus. 2003;14:e10.
56. Pollock BE, Nippoldt TB, Stafford SL, et al. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: Factors associated with endocrine normalization. J Neurosurg. 2002;97:525-530.
57. Martinez R, Bravo G, Burzaco J, et al. Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up. Stereotact Funct Neurosurg. 1998;70(suppl 1):110-118.
58. Morange-Ramos I, Regis J, Dufour H, et al. Gamma-knife surgery for secreting pituitary adenomas. Acta Neurochir (Wien). 1998;140:437-443.
59. Kim MS, Lee SI, Sim JH. Gamma Knife radiosurgery for functioning pituitary microadenoma. Stereotact Funct Neurosurg. 1999;72(suppl 1): 119-124.
60. Izawa M, Hayashi M, Nakaya K, et al. Gamma knife radiosurgery for pituitary adenomas. J Neurosurg. 2000;93(suppl 3):19-22.
61. Landolt AM, Lomax N. Gamma knife radiosurgery for prolactinomas. J Neurosurg. 2000;93(suppl 3):14-18.
62. Pan L, Zhang N, Wang EM, et al. Gamma knife radiosurgery as a primary treatment for prolactinomas. J Neurosurg. 2000;93(suppl 3):10-13. (Pubitemid 32799537)
63. Feigl GC, Bonelli CM, Berghold A, et al. Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg. 2002;97:415-421.
64. Choi JY, Chang JH, Chang JW, et al. Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery. Yonsei Med J. 2003;44:602-607.
65. Petrovich Z, Yu C, Giannotta SL, et al. Gamma knife radiosurgery for pituitary adenoma: Early results. Neurosurgery. 2003;53:51-59; discussion 59-61.
66. Kuo JS, Chen JC, Yu C, et al. Gamma knife radiosurgery for benign cavernous sinus tumors: Quantitative analysis of treatment outcomes. Neurosurgery. 2004;54:1385-1393; discussion 1393-11384
67. Ma ZM, Qiu B, Hou YH, et al. Gamma knife treatment for pituitary prolactinomas [in Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006;31:714-716.
68. Pouratian N, Sheehan J, Jagannathan J, et al. Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery. 2006;59: 255-266; discussion 255-266.
69. Pamir MN, Kilic T, Belirgen M, et al. Pituitary adenomas treated with gamma knife radiosurgery: Volumetric analysis of 100 cases with minimum 3 year follow-up. Neurosurgery. 2007;61:270 -280; discussion 280.
70. Carpenter PC. Diagnostic evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am. 1988;17:445-472.
71. Gross BA, Mindea SA, Pick AJ, et al. Diagnostic approach to Cushing's disease. Neurosurg Focus. 2007;23:E1.
72. Weiss MH, Couldwell WT. Gamma knife surgery for Cushing's disease. J Neurosurg. 2007;106:976 -977; discussion 977-979.
73. Mampalam TJ, Tyrrell JB, Wilson CB. Transsphenoidal microsurgery for Cushing's disease. A report of 216 cases. Ann Intern Med. 1988;109:487-493.
74. Robert F, Hardy J. Cushing's disease: A correlation of radiological, surgical and pathological findings with therapeutic results. Pathol Res Pract. 1991; 187:617-621.
75. Tindall GT, Herring CJ, Clark RV, et al. Cushing's disease: Results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg. 1990;72:363-369.
76. Cavagnini F, Pecori Giraldi F. Epidemiology and follow-up of Cushing's disease. Ann Endocrinol (Paris). 2001;62:168-172.
77. Chee GH, Mathias DB, James RA, et al. Transsphenoidal pituitary surgery in Cushing's disease: Can we predict outcome? Clin Endocrinol (Oxf). 2001;54:617-626.
78. Rees DA, Hanna FW, Davies JS, et al. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf). 2002;56:541-551.
79. Shimon I, Ram Z, Cohen ZR, et al. Transsphenoidal surgery for Cushing's disease: Endocrinological follow-up monitoring of 82 patients. Neurosurgery. 2002;51:57- 61; discussion 61-62.
80. Yap LB, Turner HE, Adams CB, et al. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: A single centre audit. Clin Endocrinol (Oxf). 2002;56:25-31.
81. Chen JC, Amar AP, Choi S, et al. Transsphenoidal microsurgical treatment of Cushing's disease: Postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg. 2003;98:967-973.
82. Flitsch J, Knappe UJ, Ludecke DK. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease. Zentralbl Neurochir. 2003;64:6-11.
83. Pereira AM, van Aken MO, van Dulken H, et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab. 2003;88:5858-5864.
84. Hammer GD, Tyrrell JB, Lamborn KR, et al. Transsphenoidal microsurgery for Cushing's disease: Initial outcome and long-term results. J Clin Endocrinol Metab. 2004;89:6348-6357.
85. Hofmann BM, Fahlbusch R. Treatment of Cushing's disease: A retrospective clinical study of the latest 100 cases. Front Horm Res. 2006;34:158-184.
86. Rollin G, Ferreira NP, Czepielewski MA. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. Arq Bras Endocrinol Metabol. 2007;51:1355-1361.
87. Hofmann BM, Hlavac M, Martinez R, et al. Long-term results after microsurgery for Cushing's disease: Experience with 426 primary operations over 35 years. J Neurosurg. 2008;108:9-18.
88. Orth DN, Liddle GW. Results of treatment in 108 patients with Cushing's syndrome. N Engl J Med. 1971;285:243-247.
89. Dohan FC, Boucot N, Raventos A, et al. Roentgen therapy in Cushing's syndrome without adrenocortical tumor. J Clin Endocrinol Metab. 1957;17: 8-32.
90. Heuschele R, Lampe I. Pituitary irradiation for Cushing's syndrome. Radiol Clin Biol. 1967;36:27-31.
91. Edmonds MW, Simpson WJ, Meakin JW. External irradiation of the hypophysis for Cushing's disease. Can Med Assoc J. 1972;107:860-862.
92. Grigsby PW, Simpson JR, Stokes S, et al. Results of surgery and irradiation or irradiation alone for pituitary adenomas. J Neurooncol. 1988;6:129-134.
93. Salinger DJ, Brady LW, Miyamoto CT. Radiation therapy in the treatment of pituitary adenomas. Am J Clin Oncol. 1992;15:467-473.
94. Estrada J, Boronat M, Mielgo M, et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med. 1997;336:172-177.
95. Minniti G, Osti M, Jaffrain-Rea ML, et al. Long-term follow-up results of postoperative radiation therapy for Cushing's disease. J Neurooncol. 2007; 84:79-84.
96. Littley MD, Shalet SM, Beardwell CG, et al. Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease. Clin Endocrinol (Oxf). 1990;33:445-455.
97. Tsang RW, Brierley JD, Panzarella T, et al. Radiation therapy for pituitary adenoma: Treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 1994;30:557-565.
98. Welsh J, Wharam MD, Nauta H, et al. Stereotactic radiotherapy for Cushing's disease and prolactinoma. J Radiosurg. 1999;2:23-29.
99. Laws ER, Sheehan JP, Sheehan JM, et al. Stereotactic radiosurgery for pituitary adenomas: A review of the literature. J Neurooncol. 2004;69: 257-272.
100. Hoybye C, Grenback E, Rahn T, et al. Adrenocorticotropic hormoneproducing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery. 2001;49:284 -291; discussion 291-1282
101. Degerblad M, Rahn T, Bergstrand G, et al. Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing's disease. Acta Endocrinol (Copenh). 1986;112:310-314. (Pubitemid 16061979)
102. Jagannathan J, Sheehan JP, Pouratian N, et al. Gamma knife surgery for Cushing's disease. J Neurosurg. 2007;106:980-987.
103. Castinetti F, Nagai M, Dufour H, et al. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. Eur J Endocrinol. 2007;156:91-98.
104. Inoue HK, Kohga H, Hirato M, et al. Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: Experience in 122 cases. Stereotact Funct Neurosurg. 1999;72(suppl 1):125-131.
105. Kobayashi T, Kida Y, Mori Y. Gamma knife radiosurgery in the treatment of Cushing's disease: Long-term results. J Neurosurg. 2002;97:422-428.
106. Devin JK, Allen GS, Cmelak AJ, et al. The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease. Stereotact Funct Neurosurg. 2004;82:254-262.
107. Nelson DH, Meakin JW, Thorn GW. ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome. Ann Intern Med. 1960; 52:560-569.
108. Minniti G, Brada M. Radiotherapy and radiosurgery for Cushing's disease. Arq Bras Endocrinol Metabol. 2007;51:1373-1380.
109. Howlett TA, Plowman PN, Wass JA, et al. Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: Long-term follow-up. Clin Endocrinol (Oxf). 1989;31:309-323.
110. Jenkins PJ, Trainer PJ, Plowman PN, et al. The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropindependent Cushing's syndrome. J Clin Endocrinol Metab. 1995;80:165-171.
111. Mauermann WJ, Sheehan JP, Chernavvsky DR, et al. Gamma knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy. J Neurosurg. 2007;106:988-993.
112. Marie P. Sur deux cas d'acromegalie: Hypertophie singuliere non congenitale des extremeties superieres, inferieures et cephalique [in French]. Rev Med. 1886;6:297.
113. Cushing H, Davidoff LM. The Pathological Findings in Four Autopsied Cases of Acromegaly With a Discussion of Their Significance (Monograph 22). New York, NY: The Rockefeller Institute for Medical Research; 1927.
114. Wright AD, Hill DM, Lowy C, et al. Mortality in acromegaly. Q J Med. 1970;39:1-16.
115. Rokkas T, Pistiolas D, Sechopoulos P, et al. Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis. World J Gastroenterol. 2008;14: 3484-3489.
116. Baris D, Gridley G, Ron E, et al. Acromegaly and cancer risk: A cohort study in Sweden and Denmark. Cancer Causes Control. 2002;13:395-400.
117. Orme SM, McNally RJ, Cartwright RA, et al; United Kingdom Acromegaly Study Group. Mortality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab. 1998;83:2730-2734.
118. Melmed S, Casanueva FF, Cavagnini F, et al. Guidelines for acromegaly management. J Clin Endocrinol Metab. 2002;87:4054-4058.
119. Newman CB, Melmed S, Snyder PJ, et al. Safety and efficacy of long-term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients-a clinical research center study. J Clin Endocrinol Metab. 1995; 80:2768-2775.
120. Lamberts SW, van der Lely AJ, de Herder WW, et al. Octreotide. N Engl J Med. 1996;334:246-254.
121. Jaffe CA, Barkan AL. Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am. 1992;21:713-735.
122. Laws ER, Vance ML, Thapar K. Pituitary surgery for the management of acromegaly. Horm Res. 2000;53(suppl 3):71-75.
123. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical cure. Eur J Endocrinol. 2005;152:379-387.
124. Barrande G, Pittino-Lungo M, Coste J, et al. Hormonal and metabolic effects of radiotherapy in acromegaly: Long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab. 2000;85:3779-3785.
125. Biermasz NR, van Dulken H, Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab. 2000;85:2476 -2482.
126. Powell JS, Wardlaw SL, Post KD, et al. Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab. 2000;85:2068-2071.
127. Cozzi R, Barausse M, Asnaghi D, et al. Failure of radiotherapy in acromegaly. Eur J Endocrinol. 2001;145:717-726.
128. Epaminonda P, Porretti S, Cappiello V, et al. Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS), and IGFBP-3 levels in acromegaly. Clin Endocrinol (Oxf). 2001;55:183-189.
129. Minniti G, Jaffrain-Rea ML, Osti M, et al. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf). 2005;62:210-216.
130. Jenkins PJ, Bates P, Carson MN, et al. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab. 2006;91:1239-1245.
131. Jallad RS, Musolino NR, Salgado LR, et al. Treatment of acromegaly: Is there still a place for radiotherapy? Pituitary. 2007;10:53-59.
132. Barkan AL, Halasz I, Dornfeld KJ, et al. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab. 1997;82:3187-3191.
133. Sheehan JP, Niranjan A, Sheehan JM, et al. Stereotactic radiosurgery for pituitary adenomas: An intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg. 2005;102:678-691.
134. Witt TC, Kondziolka D, Flickinger JC. Gamma knife radiosurgery for pituitary tumors. In: Lunsford LD, Kondziolka D, Flickinger JC, eds. Gamma Knife Brain Surgery. Vol.14. Basel, Switzerland: Karger; 1998.
135. Zhang N, Pan L, Wang EM, et al. Radiosurgery for growth hormoneproducing pituitary adenomas. J Neurosurg. 2000;93(suppl 3):6-9.
136. Attanasio R, Epaminonda P, Motti E, et al. Gamma-knife radiosurgery in acromegaly: A 4-year follow-up study. J Clin Endocrinol Metab. 2003;88: 3105-3112.
137. Castinetti F, Taieb D, Kuhn JM, et al. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: Correlation with initial hypersecretion. J Clin Endocrinol Metab. 2005;90:4483-4488.
138. Jezkova J, Marek J, Hana V, et al. Gamma knife radiosurgery for acromegaly- long-term experience. Clin Endocrinol (Oxf). 2006;64:588-595.
139. Pollock BE, Jacob JT, Brown PD, et al. Radiosurgery of growth hormoneproducing pituitary adenomas: Factors associated with biochemical remission. J Neurosurg. 2007;106:833-838.
140. Vik-Mo EO, Oksnes M, Pedersen PH, et al. Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol. 2007;157:255-263.
141. Snyder PJ. Clinically nonfunctioning pituitary adenomas. Endocrinol Metab Clin North Am. 1993;22:163-175.
142. Wang H, Sun W, Fu Z, et al. The pattern of visual impairment in patients with pituitary adenoma. J Int Med Res. 2008;36:1064-1069.
143. Ferrante E, Ferraroni M, Castrignano T, et al. Nonfunctioning pituitary adenoma database: A useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol. 2006;155:823-829.
144. Greenman Y, Ouaknine G, Veshchev I, et al. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: Markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf). 2003;58:763-769.
145. Turner HE, Stratton IM, Byrne JV, et al. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation-a follow-up study. Clin Endocrinol (Oxf). 1999;51:281-284.
146. Dekkers OM, Pereira AM, Roelfsema F, et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab. 2006;91:1796-1801.
147. Jaffrain-Rea ML, Derome P, Bataini JP, et al. Influence of radiotherapy on long-term relapse in clinically nonsecreting pituitary adenomas: A retrospective study (1970 -1988). Eur J Med. 1993;2:398-403.
148. Gittoes NJ, Bates AS, Tse W, et al. Radiotherapy for nonfunction pituitary tumours. Clin Endocrinol (Oxf). 1998;48:331-337.
149. Brada M, Rajan B, Traish D, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf). 1993;38:571-578.
150. Mingione V, Yen CP, Vance ML, et al. Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurg. 2006;104:876-883.
151. Iwai Y, Yamanaka K, Yoshioka K. Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery. 2005;56:699 -705; discussion 699-705.
152. Pollock BE, Cochran J, Natt N, et al. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: Results from a 15-year experience. Int J Radiat Oncol Biol Phys. 2008;70:1325-1329.
153. Plowman PN. Pituitary adenoma radiotherapy-when, who, and how? Clin Endocrinol (Oxf). 1999;51:265-271.
154. Tishler RB, Loeffler JS, Lunsford LD, et al. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys. 1993;27: 215-221.
155. Losa M, Valle M, Mortini P, et al. Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg. 2004;100:438-444.
156. van Beek AP, van den Bergh AC, van den Berg LM, et al. Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma. Int J Radiat Oncol Biol Phys. 2007;68:986-991.